Why research on resveratrol-mediated cardioprotection should not decelerate1This editorial was invited by the Editors.
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Why research on resveratrol-mediated cardioprotection should not decelerate1This editorial was invited by the Editors.
Authors
Keywords
-
Journal
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
Volume 90, Issue 5, Pages iii-vi
Publisher
Canadian Science Publishing
Online
2012-05-05
DOI
10.1139/y2012-065
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Polyphenols Resveratrol and S17834 Prevent the Structural and Functional Sequelae of Diet-Induced Metabolic Heart Disease in Mice
- (2012) Fuzhong Qin et al. CIRCULATION
- Cardiovascular effects and molecular targets of resveratrol
- (2012) Huige Li et al. NITRIC OXIDE-BIOLOGY AND CHEMISTRY
- Resveratrol: a cardioprotective substance
- (2011) Joseph M. Wu et al. Annals of the New York Academy of Sciences
- Resveratrol attenuates doxorubicin-induced cardiomyocyte apoptosis in mice through SIRT1-mediated deacetylation of p53
- (2011) C. Zhang et al. CARDIOVASCULAR RESEARCH
- Resveratrol in the Prevention and Treatment of Coronary Artery Disease
- (2011) Louis M. Chu et al. Current Atherosclerosis Reports
- Resveratrol Improves Cardiovascular Function in DOCA-Salt Hypertensive Rats
- (2011) Vincent Chan et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Regeneration of infarcted myocardium with resveratrol-modified cardiac stem cells
- (2011) Nikolai Gorbunov et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Resveratrol Improves Survival, Hemodynamics and Energetics in a Rat Model of Hypertension Leading to Heart Failure
- (2011) Stéphanie Rimbaud et al. PLoS One
- Resveratrol improves left ventricular diastolic relaxation in type 2 diabetes by inhibiting oxidative/nitrative stress: in vivo demonstration with magnetic resonance imaging
- (2010) Hanrui Zhang et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Effects of Longevinex (modified resveratrol) on cardioprotection and its mechanisms of action
- (2010) Subhendu Mukherjee et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- Insulin and resveratrol act synergistically, preventing cardiac dysfunction in diabetes, but the advantage of resveratrol in diabetics with acute heart attack is antagonized by insulin
- (2010) Jiung-Pang Huang et al. FREE RADICAL BIOLOGY AND MEDICINE
- Induction of Manganese Superoxide Dismutase by Nuclear Translocation and Activation of SIRT1 Promotes Cell Survival in Chronic Heart Failure
- (2010) Masaya Tanno et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Red wine antioxidant resveratrol-modified cardiac stem cells regenerate infarcted myocardium
- (2010) Narasimman Gurusamy et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Resveratrol Arrests and Regresses the Development of Pressure Overload- but Not Volume Overload-Induced Cardiac Hypertrophy in Rats
- (2010) Peter Wojciechowski et al. JOURNAL OF NUTRITION
- Resveratrol improves cardiovascular function and reduces oxidative organ damage in the renal, cardiovascular and cerebral tissues of two-kidney, one-clip hypertensive rats
- (2010) Hale Z. Toklu et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Resveratrol Prevents the Development of Pathological Cardiac Hypertrophy and Contractile Dysfunction in the SHR Without Lowering Blood Pressure
- (2009) S. J. Thandapilly et al. AMERICAN JOURNAL OF HYPERTENSION
- Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy
- (2009) M. Sulaiman et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Resveratrol: a promising agent in promoting cardioprotection against coronary heart diseaseThis article is one of a selection of papers from the NATO Advanced Research Workshop on Translational Knowledge for Heart Health (published in part 2 of a 2-part Special Issue).
- (2009) Suresh Varma Penumathsa et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- Resveratrol Prevents the Prohypertrophic Effects of Oxidative Stress on LKB1
- (2009) Vernon W. Dolinsky et al. CIRCULATION
- Resveratrol inhibits right ventricular hypertrophy induced by monocrotaline in rats
- (2009) Dan-Li Yang et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Resveratrol treatment protects against doxorubicin-induced cardiotoxicity by alleviating oxidative damage
- (2009) Elif Tatlidede et al. FREE RADICAL RESEARCH
- Resveratrol Prevents Monocrotaline-Induced Pulmonary Hypertension in Rats
- (2009) Anna Csiszar et al. HYPERTENSION
- Resveratrol Attenuates Ventricular Arrhythmias and Improves the Long-Term Survival in Rats with Myocardial Infarction
- (2008) You-Ren Chen et al. CARDIOVASCULAR DRUGS AND THERAPY
- Mechanism for resveratrol-induced cardioprotection against reperfusion injury involves glycogen synthase kinase 3β and mitochondrial permeability transition pore
- (2008) Jinkun Xi et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Resveratrol reduces infarct size and improves ventricular function after myocardial ischemia in rats
- (2008) Jeng-Feng Lin et al. LIFE SCIENCES
- A Low Dose of Dietary Resveratrol Partially Mimics Caloric Restriction and Retards Aging Parameters in Mice
- (2008) Jamie L. Barger et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started